ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹937 Cr | ₹784 Cr | ₹703 Cr | ₹645 Cr | ₹544 Cr |
What is the latest Net Current Assets ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹937 Cr |
| Mar2025 | ₹784 Cr |
| Mar2024 | ₹703 Cr |
| Mar2023 | ₹645 Cr |
| Mar2022 | ₹544 Cr |
How is Net Current Assets of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹937 Cr | 19.55 | |
| Mar2025 | ₹784 Cr | 11.41 | |
| Mar2024 | ₹703 Cr | 9.13 | |
| Mar2023 | ₹645 Cr | 18.48 | |
| Mar2022 | ₹544 Cr | - | |
Compare Net Current Assets of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,179.1 Cr | -4.4% | -4.4% | -13.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -4.4% |
-4.4% |
-13.8% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses